Maria Massaro
Via Manzoni 56, Rozzano
Milan, 20089, Italy
Milan, 20089, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective study.
Journal: Radiation oncology (London, England)
Published: December 03, 2025
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).
Journal: Current oncology (Toronto, Ont.)
Published: May 31, 2023
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
Journal: Journal of cancer research and clinical oncology
Published: April 19, 2023
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Journal: The British journal of radiology
Published: February 22, 2023
Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review.
Journal: Journal of gastrointestinal oncology
Published: August 27, 2022
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: August 24, 2022
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy.
Journal: Current oncology (Toronto, Ont.)
Published: May 20, 2022
Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
Journal: Journal of cancer research and clinical oncology
Published: August 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026